RBOT News and Press, Vicarious Surgical Inc Com Cl A From 02/12/24

Verde Clean Fuels Inc. (VGAS) is expected to report for Q4 2023 Pioneer Bancorp Inc. (PBFS) is expected to report for Q2 2024 Equity Commonwealth of Beneficial Interest (EQC) is expected to report $0.27 for Q4 2023 monday.com Ltd. (MNDY) is expected to report $-0.31 for Q4 2023 As...

2024-01-29 08:42:15 ET More on Vicarious Surgical Vicarious Surgical Inc. 2023 Q3 - Results - Earnings Call Presentation Vicarious Surgical Inc. (RBOT) Q3 2023 Earnings Call Transcript Canaccord cuts Vicarious Surgical to hold, cites timelines delays Seeking ...

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that Randy Clark has...

2023-11-15 15:33:32 ET More on Vicarious Surgical Vicarious Surgical Inc. 2023 Q3 - Results - Earnings Call Presentation Vicarious Surgical Inc. (RBOT) Q3 2023 Earnings Call Transcript Vicarious Surgical: Huge Potential But Low Margin Of Safety To Commercialization ...

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the Company will pre...

2023-11-13 20:05:06 ET Vicarious Surgical Inc. (RBOT) Q3 2023 Earnings Conference Call November 13, 2023, 16:30 PM ET Company Participants Kaitlyn Brosco - Investor Relations Adam Sachs - Chief Executive Officer Bill Kelly - Chief Financial Officer Conferen...

2023-11-13 16:22:34 ET More on Vicarious Surgical Vicarious Surgical: Huge Potential But Low Margin Of Safety To Commercialization Vicarious Surgical receives continued listing standard notice from NYSE For further details see: Vicarious Surgical Non-GAAP EPS of ...

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results fo...

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...

Vicarious Surgical Inc. Class A (RBOT) is expected to report $-0.15 for Q3 2023